chrX-18609570-G-A
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PS3_SupportingPM2_SupportingPM6_StrongPP4PS4
This summary comes from the ClinGen Evidence Repository: The p.Val718Met variant in CDKL5 has been reported in at least 2 de novo occurrences (biological parentage unconfirmed) in individuals with a CDKL5-related disorder (PMID 18790821, 27599155) (PM6_strong). The p.Val718Met variant has been observed at least 5 individuals with CDKL5-related disorders (PMID 31313283, 18790821, 27599155, GeneDx internal database) (PS4), including in an individual with a clinical phenotype very specific to a CDKL5-related disorder (PMID 27599155) (PP4). Additionally, an in vitro study using a minigene splicing assay showed that splicing is disrupted, resulting in exon 14 being omitted from the transcript (PMID:29264392) (PS3_supporting). The p.Val718Met variant in CDKL5 is absent from gnomAD v4.1 (PM2_Supporting). In summary, the p.Val718Met variant in CDKL5 is classified as pathogenic for CDKL5-related disorders based on the ACMG/AMP criteria (PM6_strong, PS4, PP4, PS3_supporting, PM2_supporting). (CDKL5 Specifications v.4.1; curation approved on [5/7/2025]) LINK:https://erepo.genome.network/evrepo/ui/classification/CA199279/MONDO:0100039/034
Frequency
Consequence
NM_001323289.2 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001323289.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKL5 | NM_001323289.2 | MANE Select | c.2152G>A | p.Val718Met | missense splice_region | Exon 14 of 18 | NP_001310218.1 | ||
| CDKL5 | NM_001037343.2 | c.2152G>A | p.Val718Met | missense splice_region | Exon 15 of 22 | NP_001032420.1 | |||
| CDKL5 | NM_003159.3 | c.2152G>A | p.Val718Met | missense splice_region | Exon 14 of 21 | NP_003150.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKL5 | ENST00000623535.2 | TSL:1 MANE Select | c.2152G>A | p.Val718Met | missense splice_region | Exon 14 of 18 | ENSP00000485244.1 | ||
| CDKL5 | ENST00000379989.6 | TSL:1 | c.2152G>A | p.Val718Met | missense splice_region | Exon 15 of 22 | ENSP00000369325.3 | ||
| CDKL5 | ENST00000379996.7 | TSL:1 | c.2152G>A | p.Val718Met | missense splice_region | Exon 14 of 21 | ENSP00000369332.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
CDKL5 disorder Pathogenic:1Uncertain:1
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as a variant of uncertain significance. At least the following criteria are met: This variant has been identified as a de novo occurrence in an individual with CDKL5 disorder without confirmation of paternity and maternity (PM6, PMID: 18790821). This variant is absent from gnomAD (PM2_Supporting).
The p.Val718Met variant in CDKL5 has been reported in at least 2 de novo occurrences (biological parentage unconfirmed) in individuals with a CDKL5-related disorder (PMID 18790821, 27599155) (PM6_strong). The p.Val718Met variant has been observed at least 5 individuals with CDKL5-related disorders (PMID 31313283, 18790821, 27599155, GeneDx internal database) (PS4), including in an individual with a clinical phenotype very specific to a CDKL5-related disorder (PMID 27599155) (PP4). Additionally, an in vitro study using a minigene splicing assay showed that splicing is disrupted, resulting in exon 14 being omitted from the transcript (PMID: 29264392) (PS3_supporting). The p.Val718Met variant in CDKL5 is absent from gnomAD v4.1 (PM2_Supporting). In summary, the p.Val718Met variant in CDKL5 is classified as pathogenic for CDKL5-related disorders based on the ACMG/AMP criteria (PM6_strong, PS4, PP4, PS3_supporting, PM2_supporting). (CDKL5 Specifications v.4.1; curation approved on [5/7/2025])
Developmental and epileptic encephalopathy, 2 Pathogenic:1
No parental studies; highly conserved residue; In silico prediction: SIFT = deleterious, MutationTaster = disease-causing, PolyPhen2 = probably damaging, AlignGVGD = benign (C0)
not provided Pathogenic:1
The V718M missense mutation in the CDKL5 gene has been reported previously as a de novo mutation in a patient with infantile spasms, microcephaly with deceleration of head growth, severe intellectual disability, and limited hand skills (Bahi-Buisson et al., 2008). This mutation alters a highly conserved position in the C-terminal region of the protein. The variant is found in INFANT-EPI panel(s).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at